Axon Enterprise, Inc $AXON Stock Purchased by CENTRAL TRUST Co

CENTRAL TRUST Co lifted its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 3,086.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 147,028 shares of the biotechnology company’s stock after acquiring an additional 142,414 shares during the quarter. Axon Enterprise makes up approximately 1.1% of CENTRAL TRUST Co’s holdings, making the stock its 24th largest holding. CENTRAL TRUST Co owned about 0.18% of Axon Enterprise worth $62,122,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. State Street Corp increased its holdings in Axon Enterprise by 5,700.2% during the 2nd quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock valued at $119,724,905,000 after purchasing an additional 209,879,882 shares in the last quarter. Envestnet Asset Management Inc. raised its position in Axon Enterprise by 18,050.2% in the 2nd quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock valued at $7,400,094,000 after purchasing an additional 13,127,348 shares during the last quarter. BlackRock Inc. boosted its stake in Axon Enterprise by 4.3% in the second quarter. BlackRock Inc. now owns 8,334,551 shares of the biotechnology company’s stock worth $4,672,432,000 after purchasing an additional 345,365 shares in the last quarter. Robeco Institutional Asset Management B.V. boosted its stake in Axon Enterprise by 391,214.9% in the third quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company’s stock worth $2,952,943,000 after purchasing an additional 6,987,098 shares in the last quarter. Finally, The Manufacturers Life Insurance Company boosted its stake in Axon Enterprise by 8,432.6% in the second quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company’s stock worth $1,983,414,000 after purchasing an additional 3,496,493 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Axon Enterprise Stock Up 4.3%

Shares of NASDAQ:AXON opened at $315.42 on Thursday. Axon Enterprise, Inc has a one year low of $291.45 and a one year high of $665.07. The company has a 50 day moving average of $426.24 and a 200-day moving average of $470.65. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.00 and a quick ratio of 2.60. The stock has a market cap of $25.68 billion, a price-to-earnings ratio of 101.10, a P/E/G ratio of 5.75 and a beta of 1.48.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The business had revenue of $908.55 million for the quarter, compared to the consensus estimate of $934.33 million. During the same period last year, the firm earned $1.17 earnings per share. The company’s quarterly revenue was up 27.8% on a year-over-year basis. On average, sell-side analysts forecast that Axon Enterprise, Inc will post 2.10 earnings per share for the current year.

Insider Buying and Selling at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total value of $5,089,900.00. Following the transaction, the chief executive officer owned 3,118,012 shares of the company’s stock, valued at $1,587,036,927.88. This represents a 0.32% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the stock in a transaction on Monday, August 31st. The shares were sold at an average price of $574.43, for a total value of $9,636,063.25. Following the completion of the transaction, the president directly owned 296,974 shares in the company, valued at approximately $170,590,774.82. This trade represents a 5.35% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 37,397 shares of company stock worth $21,234,034 over the last quarter. 4.20% of the stock is currently owned by insiders.

More Axon Enterprise News

These are some of the AXON news items that stood out recently:

• Positive Sentiment: Axon’s integrated public-safety hardware and software ecosystem, along with continued revenue growth, are cited as reasons it could remain a long-term growth company despite its 2026 share-price decline. 3 Superior Growth Stocks That Can Outperform for the Next 10 Years
• Neutral Sentiment: Axon is investing $1.2 billion for a 37% stake in drone maker Skydio and will distribute its products to U.S. public-safety customers. The deal could broaden Axon’s offering, but its sizeable cost makes the investment a factor for investors to weigh. Axon invests $1.2B into Skydio and becomes its U.S. public safety distributor
• Negative Sentiment: Axon’s third-quarter adjusted EPS missed Wall Street expectations, and cautious guidance contributed to a sharp share decline. The company also said federal contract delays shifted $130 million of revenue out of 2026, weighing on near-term expectations. Axon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?

Analyst Ratings Changes

AXON has been the topic of several research analyst reports. Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 3rd. Needham & Company LLC cut their price target on Axon Enterprise from $750.00 to $500.00 and set a “buy” rating for the company in a report on Friday, November 6th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a research report on Tuesday, November 3rd. JPMorgan Chase & Co. reduced their price target on shares of Axon Enterprise from $755.00 to $610.00 and set an “overweight” rating on the stock in a research report on Friday, November 6th. Finally, The Goldman Sachs Group decreased their price objective on shares of Axon Enterprise from $715.00 to $675.00 and set a “buy” rating on the stock in a report on Monday, September 21st. Thirteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $612.18.

Axon Enterprise Company Profile

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.